Display Options:
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Breast Neoplasms; Neoplasms
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Hypersensitivity
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Atrial Fibrillation; Heart Failure; Arrhythmias, Cardiac
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Glucocorticoid receptor agonist
ROUTE OF ADMINISTRATION: TOPICAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Histamine H1 receptor antagonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER; RESPIRATORY
THERAPEUTIC INDICATION: Hypersensitivity; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis; Common Cold; Rhinitis, Allergic; Rhinitis, Allergic, Seasonal; Urticaria
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Histamine H2 receptor antagonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: GASTROINTESTINAL; OTHER
THERAPEUTIC INDICATION: Amyotrophic Lateral Sclerosis; Anxiety Disorders; Infections; Pulmonary Disease, Chronic Obstructive; Breast Carcinoma In Situ; Endometrial Neoplasms; Protoporphyria, Erythropoietic; Dermatitis, Atopic; Gastrointestinal Hemorrhage; Hemorrhage; Ulcer; Duodenal Ulcer; Gastroesophageal Reflux; Heartburn; Peptic Ulcer
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Optic Neuritis; Urticaria; Angioedema; Dermatitis; Hypersensitivity; Pruritus
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Estrogen receptor alpha agonist
ROUTE OF ADMINISTRATION: ORAL; VAGINAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Atrophy; Hypogonadism; Menopause; Osteoporosis; Primary Ovarian Insufficiency
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Estrogen receptor agonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: DIABETES DRUGS & ENDOCRINOLOGY; MUSCULOSKELETAL; OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Bone Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: GABA-B receptor agonist
ROUTE OF ADMINISTRATION: INTRATHECAL; ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Autistic Disorder; Liver Cirrhosis, Alcoholic; Obesity; Carcinoma, Hepatocellular; Cocaine-Related Disorders; Marijuana Abuse; Paget Disease, Extramammary; Pain; Tobacco Use Disorder; Alcoholism; Charcot-Marie-Tooth Disease; Gastroesophageal Reflux; Substance Withdrawal Syndrome; Brain Injuries; Brain Injuries, Traumatic; Cerebral Palsy; Multiple Sclerosis; Muscle Contraction; Muscle Rigidity; Muscle Spasticity; Spinal Cord Diseases; Spinal Cord Injuries
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Histamine H1 receptor antagonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: DNA inhibitor
ROUTE OF ADMINISTRATION: INJECTION; INTRACRANIAL
STATUS: Approved
THERAPEUTIC AREA: DIABETES DRUGS & ENDOCRINOLOGY; OTHER
THERAPEUTIC INDICATION: Leukemia, Plasma Cell; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Neuroblastoma; Sezary Syndrome; Brain Neoplasms; Colorectal Neoplasms; Gliosarcoma; Graft vs Host Disease; Hematologic Diseases; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Melanoma; Multiple Sclerosis, Relapsing-Remitting; Myasthenia Gravis; Neuromyelitis Optica; Opsoclonus-Myoclonus Syndrome; Ovarian Neoplasms; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Prostatic Neoplasms, Castration-Resistant; Sarcoma; Stiff-Person Syndrome; Breast Neoplasms; Central Nervous System Neoplasms; Leukemia; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Oligodendroglioma; Astrocytoma; Ependymoma; Glioblastoma; Glioma; Hodgkin Disease; Medulloblastoma; Multiple Myeloma; Neoplasms
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: INTRAVESICAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: HIV Infections; Melanoma; Neoplasms; Osteoarthritis; Contracture; Cystitis, Interstitial; Reflex, Abnormal; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Arthralgia; Cystitis; Infections; Myalgia
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: GABA-A receptor; anion channel positive allosteric modulator
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Substance-Related Disorders; Anxiety; Dementia; Depressive Disorder; Schizophrenia; Sleep Initiation and Maintenance Disorders
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Cyclooxygenase inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Breast Neoplasms; Carcinoma, Squamous Cell; Fibromatosis, Aggressive; Fragile X Syndrome; Leukemia, Myeloid, Acute; Melanoma; Adenomatous Polyposis Coli; Colorectal Neoplasms; Precancerous Conditions; Arthritis, Rheumatoid; Osteoarthritis; Rheumatic Diseases; Spondylitis
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Vitamin D receptor agonist
ROUTE OF ADMINISTRATION: INJECTION; ORAL; TOPICAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Attention Deficit Disorder with Hyperactivity; Carcinoma, Non-Small-Cell Lung; Central Nervous System Neoplasms; Crohn Disease; Melanoma; Mouth Neoplasms; Neoplasms; Osteoporosis, Postmenopausal; Prediabetic State; Acute Kidney Injury; Breast Neoplasms; Carcinoma, Basal Cell; Cholangiocarcinoma; Chronic Kidney Disease-Mineral and Bone Disorder; Diabetes Mellitus, Type 1; Hypertension; Klinefelter Syndrome; Lupus Erythematosus, Systemic; Myelodysplastic Syndromes; Pancreatic Neoplasms; Prostatic Neoplasms; Sepsis; Adenomatous Polyposis Coli; Diabetic Nephropathies; Fibroma; Osteopetrosis; Osteoporosis; Prostatic Neoplasms, Castration-Resistant; Hypocalcemia; Hypoparathyroidism; Kidney Failure, Chronic; Psoriasis
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Pancreatic Neoplasms; Bacterial Infections
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Bacterial penicillin-binding protein inhibitor
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Tuberculosis, Pulmonary; Bacterial Infections; Infections; Pharyngitis
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Cyclooxygenase inhibitor
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Succinate semialdehyde dehydrogenase inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
THERAPEUTIC INDICATION: Astrocytoma; Burkitt Lymphoma; Carcinoma, Non-Small-Cell Lung; Central Nervous System Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Medulloblastoma; Nasopharyngeal Neoplasms; Neoplasms; Ovarian Neoplasms; Sarcoma; Shock; Wounds and Injuries; Alopecia; Brain Neoplasms; Breast Neoplasms; Carcinoma, Squamous Cell; Glioblastoma; Glioma; HIV Infections; Head and Neck Neoplasms; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma; Melanoma; Muscular Atrophy, Spinal; Myelodysplastic Syndromes; Neuralgia; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Retinitis Pigmentosa; Small Cell Lung Carcinoma; Supranuclear Palsy, Progressive; Thyroid Neoplasms; Anxiety; Dementia; Depressive Disorder; Paraparesis, Tropical Spastic; Schizophrenia; Status Epilepticus; Anorexia; Bipolar Disorder; Epilepsy; Epilepsy, Absence; Epilepsy, Complex Partial; Migraine Disorders; Mitochondrial Diseases; Seizures; Vomiting
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Dermatitis, Atopic; HIV Infections; Malaria; Neoplasms; Psoriasis; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Heart Diseases; Hypotension, Orthostatic; Obesity; Prader-Willi Syndrome; Premature Birth; Tachycardia, Ventricular; Ventricular Fibrillation; beta-Thalassemia; Atherosclerosis; Atrial Fibrillation; Breast Neoplasms; Coronary Disease; Diabetes Mellitus, Type 2; Heart Failure; Hypercholesterolemia; Hypertension; Myocardial Infarction; Non-ST Elevated Myocardial Infarction; ST Elevation Myocardial Infarction; Cardiovascular Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Acute Lung Injury; Brain Injuries; Shock; Shock, Septic; Heart Failure; Cardiovascular Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Adenomyosis; Alzheimer Disease; Diabetes Mellitus, Type 1; Intellectual Disability; Obesity; Ovarian Hyperstimulation Syndrome; Parkinson Disease
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: DNA inhibitor
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Anxiety; Pain
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Diagnostic agent
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Ergosterol sequestering agent
ROUTE OF ADMINISTRATION: OPHTHALMIC
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Mycoses; Acanthamoeba Keratitis; Keratitis; Eye Infections; Infections
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Beta-1 adrenergic receptor antagonist
ROUTE OF ADMINISTRATION: OPHTHALMIC
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Hemangioma; Migraine Disorders; Telangiectasia, Hereditary Hemorrhagic; Varicose Ulcer; Wet Macular Degeneration; Wounds and Injuries; Exfoliation Syndrome; Melanoma; Cardiovascular Diseases; Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Bacterial penicillin-binding protein inhibitor
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Beta-1 adrenergic receptor antagonist
ROUTE OF ADMINISTRATION: OPHTHALMIC; ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Optic Neuropathy, Ischemic; Corneal Edema; Hemangioma; Hypertension, Portal; Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension